Hetastarch for the Treatment of Perioperative Hypotension

  • E. T. Riley


There is substantial laboratory and clinical evidence that hetastarch is an effective volume replacement product. Because it tends to stay intravascular and not be distributed to the extracellular fluid space, compared to crystalloids, it causes less edema and is a more effective volume replacement. How much of an effect this has on outcome is probably small, but significant enough to justify its use in higher risk cases. Significant side effects are rare.


Hydroxyethyl Starch Volume Replacement Starch Solution Crystalloid Solution Intravascular Volume Expansion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gorin NC, Najman A, Duhamel G: Autologous bone marrow transplantation in acute myelocytic leukemia. The Lancet 8020:1050, 197711. Griffel MI, Kaufman BS: Pharmacology of colloids and crystalloids. Crit Care Clin 1992; 8: 23553Google Scholar
  2. 2.
    Behne M, Thomas H, Bremerich DH, Lischke V, Asskali F, Forster H: The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery. Anesth Analg 1998; 86: 856–60PubMedGoogle Scholar
  3. 3.
    Smiley LE: The use of hetastarch for plasma expansion. Probl Vet Med 1992; 4: 652–67PubMedGoogle Scholar
  4. 4.
    Ueyama H, Yan-Ling H, Tanigami H, Mashimo T, Yoshiya I: The effects of crystalloid and colloid preload on the blood volume in the parturient undergoing spinal anesthesia for elective Cesarean section. Anesthesiology 1996; 85: A901CrossRefGoogle Scholar
  5. 5.
    Zornow MH, Scheller MS, Todd MM, Moore SS: Acute cerebral effects of isotonic crystalloid and colloid solutions following cryogenic brain injury in the rabbit. Anesthesiology 1988; 69: 180–4PubMedCrossRefGoogle Scholar
  6. 6.
    Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P: Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 1990; 2: 317–23PubMedCrossRefGoogle Scholar
  7. 7.
    Wennberg E, Frid I, Haljamae H: Comparison of Ringer’s acetate with 3% dextran 70 for volume loading before extradural caesarean section. Br J Anaesth 1990; 65: 654–60PubMedCrossRefGoogle Scholar
  8. 8.
    Baum TD, Wang H, Rothschild HR, Gang DL, Fink MP: Mesenteric oxygen metabolism, ileal mucosal hydrogen ion concentration, and tissue edema after crystalloid or colloid resuscitation in porcine endotoxic shock: comparison of Ringer’s lactate and 6% hetastarch. Circ Shock 1990; 30: 385–97PubMedGoogle Scholar
  9. 9.
    Nielsen VG, Tan S, Brix AE, Baird MS, Parks DA: Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. Crit Care Med 1997; 25:1565–74PubMedCrossRefGoogle Scholar
  10. 10.
    Ley SJ, Miller K, Skov P, Preisig P: Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 1990; 19: 31–40PubMedGoogle Scholar
  11. 11.
    Mythen MG, Webb AR: Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995; 130: 423–9PubMedGoogle Scholar
  12. 12.
    Boldt J, Kling D, Zickmann B, Jacobi M, von Bormann B, Dapper F, Hempelmann G: Acute plasmapheresis during cardiac surgery: volume replacement by crystalloids versus colloids. J Cardiothorac Anesth 1990; 4: 564–70PubMedCrossRefGoogle Scholar
  13. 13.
    Riley ET, Cohen SE, Rubenstein AJ, Flanagan B: Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer’s solution [see comments]. Anesth Analg 1995; 81: 838–42PubMedGoogle Scholar
  14. 14.
    Tranmer BI, Iacobacci RI, Kindt GW: Effects of crystalloid and colloid infusions on intracranial pressure and computerized electroencephalographic data in dogs with vasogenic brain edema [see comments]. Neurosurgery 1989; 25:173–8; discussion 8–9PubMedCrossRefGoogle Scholar
  15. 15.
    Goulin GD, Duthie SE, Zornow MH, Serieller MS, Peterson BM: Global cerebral ischemia: effects of pentastarch after reperfusion [see comments]. Anesth Analg 1994; 79:1036–42PubMedCrossRefGoogle Scholar
  16. 16.
    Aly Hassan A, Lochbuehler H, Frey L, Messmer K: Global tissue oxygenation during normovolaemic haemodilution in young children. Paediatr Anaesth 1997; 7: 197–204CrossRefGoogle Scholar
  17. 17.
    Belcher P, Lennox SC: Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Ann Thorac Surg 1984; 37: 365–70PubMedCrossRefGoogle Scholar
  18. 18.
    Baron JF, De Kegel D, Prost AC, Mundler O, Arthaud M, Basset G, Maistre G, Masson F, Carayon A, Landault C, et al.: Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution. Intensive Care Med 1991; 17:141–8PubMedCrossRefGoogle Scholar
  19. 19.
    Cullen MJ, Singer M: Severe anaphylactoid reaction to hydroxyethyl starch. Anaesthesia 1990; 45:1041–2PubMedCrossRefGoogle Scholar
  20. 20.
    Dieterich HJ, Kraft D, Sirtl C, Laubenthal H, Schimetta W, Polz W, Gerlach E, Peter K: Hydroxyethyl starch antibodies in humans: incidence and clinical relevance. Anesth Analg 1998; 86: 1123–6PubMedGoogle Scholar
  21. 21.
    Bothner U, Georgieff M, Vogt NH: Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomized, controlled epidemiology study. Anesth Analg 1998; 86: 850–5PubMedGoogle Scholar
  22. 22.
    Treib J, Haass A: Hydroxyethyl starch [letter; comment]. J Neurosurg 1997; 86: 574–5PubMedGoogle Scholar
  23. 23.
    Treib J, Haass A, Pindur G, Grauer MT, Jung F, Wenzel E, Schimrigk K: Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneimittelforschung 1997; 47:18–22PubMedGoogle Scholar
  24. 24.
    Claes Y, Van Hemelrijck J, Van Gerven M, Arnout J, Vermylen J, Weidler B, Van Aken H: Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg 1992; 75: 24–30PubMedCrossRefGoogle Scholar
  25. 25.
    Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D: Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78: 44–50PubMedGoogle Scholar
  26. 26.
    Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients [see comments]. Anesth Analg 1996; 83: 254–61PubMedGoogle Scholar
  27. 27.
    Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS, Krön IL, Tribble CG: Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997; 63: 78–82; discussion-3PubMedCrossRefGoogle Scholar
  28. 28.
    Sharma SK, Gajraj NM, Sidawi JE: Prevention of hypotension during spinal anesthesia: a comparison of intravascular administration of hetastarch versus lactated Ringer’s solution. Anesth Analg 1997; 84:111–4PubMedGoogle Scholar
  29. 29.
    Karinen J, Rasanen J, Alahuhta S, Jouppila R, Jouppila P: Effect of crystalloid and colloid preloading on uteroplacental and maternal haemodynamic state during spinal anaesthesia for caesarean section. Br J Anaesth 1995; 75: 531–5PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • E. T. Riley

There are no affiliations available

Personalised recommendations